ARQT · Arcutis Biotherapeutics, Inc. · Investor Relations
$26.43
-0.32 (-1.20%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$3.39B
Shares
125.69M
Volume · Sep 30
2.39M
Avg daily vol (3M)
2.18M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-16 | Morgan Stanley 24th Annual Global Healthcare Conference | Conference |
| 2026-08-05 | Arcutis Biotherapeutics, Inc. Q2 2026 Earnings Conference Call | Earnings call |
| 2026-06-09 | Goldman Sachs 47th Annual Global Healthcare Conference | Conference |
| 2026-05-06 | Arcutis Biotherapeutics, Inc. Q1 2026 Earnings Conference Call | Earnings call |
| 2026-04-14 | 25th Annual Needham Virtual Healthcare Conference | Conference |
| 2026-03-02 | TD Cowen 46th Annual Health Care Conference | Conference |
| 2026-02-25 | Arcutis Biotherapeutics, Inc. Q4/FY 2025 Earnings Conference Call | Earnings call |
| 2026-02-11 | Guggenheim Emerging Outlook: Biotech Summit | Event |
| 2025-11-12 | TD Cowen Immunology & Inflammation Summit | Event |
| 2025-11-11 | Guggenheim’s 2nd Annual Healthcare Innovation Conference | Conference |
| 2025-10-28 | Arcutis Virtual Investor Day and Third Quarter 2025 Earnings Conference Call | Earnings call |
| 2025-08-06 | Arcutis Biotherapeutics, Inc. Q2 2025 Earnings Conference Call | Earnings call |
Source: https://investors.arcutis.com/